These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 10386866)

  • 21. Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes.
    Bock TA; Orlic D; Dunbar CE; Broxmeyer HE; Bodine DM
    J Exp Med; 1995 Dec; 182(6):2037-43. PubMed ID: 7500049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of gene transfer into primitive human hematopoietic cells of granulocyte-colony stimulating factor-mobilized peripheral blood using low-dose cytokines and comparison of a gibbon ape leukemia virus versus an RD114-pseudotyped retroviral vector.
    van der Loo JC; Liu BL; Goldman AI; Buckley SM; Chrudimsky KS
    Hum Gene Ther; 2002 Jul; 13(11):1317-30. PubMed ID: 12162814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice.
    Milazzo L; Vulcano F; Barca A; Macioce G; Paldino E; Rossi S; Ciccarelli C; Hassan HJ; Giampaolo A
    Eur J Haematol; 2014 Nov; 93(5):384-91. PubMed ID: 24797266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
    Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
    Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small peptide analogue of SDF-1alpha supports survival of cord blood CD34+ cells in synergy with other cytokines and enhances their ex vivo expansion and engraftment into nonobese diabetic/severe combined immunodeficient mice.
    Li K; Chuen CK; Lee SM; Law P; Fok TF; Ng PC; Li CK; Wong D; Merzouk A; Salari H; Gu GJ; Yuen PM
    Stem Cells; 2006 Jan; 24(1):55-64. PubMed ID: 16123381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of human hematopoietic stem cell populations.
    Murray L; DiGiusto D; Chen B; Chen S; Combs J; Conti A; Galy A; Negrin R; Tricot G; Tsukamoto A
    Blood Cells; 1994; 20(2-3):364-9; discussion 369-70. PubMed ID: 7538340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients.
    Lowry PA; Shultz LD; Greiner DL; Hesselton RM; Kittler EL; Tiarks CY; Rao SS; Reilly J; Leif JH; Ramshaw H; Stewart FM; Quesenberry PJ
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):15-23. PubMed ID: 9078350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of engraftment potential of human cord blood stem-progenitor cells as a function of donor cell dosage and gestational age in the NOD/SCID mouse model.
    Ural SH; Sammel MD; Blakemore KJ
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):990-4. PubMed ID: 16157099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
    Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
    Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ex vivo cytokine treatment on human cord blood engraftment in NOD-scid mice.
    Ballen K; Becker PS; Greiner D; Valinski H; Shearin D; Berrios V; Dooner G; Hsieh CC; Wuu J; Shultz L; Cerny J; Leif J; Stewart FM; Quesenberry P
    Br J Haematol; 2000 Mar; 108(3):629-40. PubMed ID: 10759723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model.
    Zheng Y; Sun A; Han ZC
    Bone Marrow Transplant; 2005 Jan; 35(2):137-42. PubMed ID: 15543197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
    de Bont ES; Guikema JE; Scherpen F; Meeuwsen T; Kamps WA; Vellenga E; Bos NA
    Cancer Res; 2001 Oct; 61(20):7654-9. PubMed ID: 11606408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term engraftment of nonobese diabetic/severe combined immunodeficient mice with human CD34+ cells transduced by a self-inactivating human immunodeficiency virus type 1 vector.
    Gatlin J; Padgett A; Melkus MW; Kelly PF; Garcia JV
    Hum Gene Ther; 2001 Jun; 12(9):1079-89. PubMed ID: 11399229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice.
    Lapidot T; Pflumio F; Doedens M; Murdoch B; Williams DE; Dick JE
    Science; 1992 Feb; 255(5048):1137-41. PubMed ID: 1372131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice.
    Lepus CM; Gibson TF; Gerber SA; Kawikova I; Szczepanik M; Hossain J; Ablamunits V; Kirkiles-Smith N; Herold KC; Donis RO; Bothwell AL; Pober JS; Harding MJ
    Hum Immunol; 2009 Oct; 70(10):790-802. PubMed ID: 19524633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.
    Pino S; Brehm MA; Covassin-Barberis L; King M; Gott B; Chase TH; Wagner J; Burzenski L; Foreman O; Greiner DL; Shultz LD
    Methods Mol Biol; 2010; 602():105-17. PubMed ID: 20012395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice.
    Gorantla S; Sneller H; Walters L; Sharp JG; Pirruccello SJ; West JT; Wood C; Dewhurst S; Gendelman HE; Poluektova L
    J Virol; 2007 Mar; 81(6):2700-12. PubMed ID: 17182671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells.
    Wiekmeijer AS; Pike-Overzet K; IJspeert H; Brugman MH; Wolvers-Tettero IL; Lankester AC; Bredius RG; van Dongen JJ; Fibbe WE; Langerak AW; van der Burg M; Staal FJ
    J Allergy Clin Immunol; 2016 Feb; 137(2):517-526.e3. PubMed ID: 26441229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathology of macrophage activation syndrome in humanized NSGS mice.
    Tarrant JC; Binder ZA; Bugatti M; Vermi W; van den Oord J; Ranieri B; Assenmacher CA; Hoepp N; O'Rourke DM; Shan X; Danet-Desnoyers G; Radaelli E
    Res Vet Sci; 2021 Jan; 134():137-146. PubMed ID: 33383491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.